Preclinical assessment of adjunctive tPA and DNase for peritoneal dialysis associated peritonitis

PloS One
Amanda L McGuireAron Chakera

Abstract

A major complication of peritoneal dialysis is the development of peritonitis, which is associated with reduced technique and patient survival. The inflammatory response elicited by infection results in a fibrin and debris-rich environment within the peritoneal cavity, which may reduce the effectiveness of antimicrobial agents and predispose to recurrence or relapse of infection. Strategies to enhance responses to antimicrobial agents therefore have the potential to improve patient outcomes. This study presents pre-clinical data describing the compatibility of tPA and DNase in combination with antimicrobial agents used for the treatment of PD peritonitis. tPA and DNase were stable in standard dialysate solution and in the presence of antimicrobial agents, and were safe when given intraperitoneally in a mouse model with no evidence of local or systemic toxicity. Adjunctive tPA and DNase may have a role in the management of patients presenting with PD peritonitis.

References

Oct 1, 1991·The Journal of Clinical Investigation·J D VassalliD Belin
Dec 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·S ShakC L Baker
Jan 1, 1985·European Journal of Clinical Pharmacology·M E McIntoshM J Brodie
Nov 24, 1998·The Annals of Pharmacotherapy·M A WorlandB A Mueller
Aug 24, 1999·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·A W de BoerL A Monnens
Oct 31, 2000·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·G C Kim, S M Korbet
Jan 3, 2001·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·J M Duch, J Yee
Mar 1, 2002·American Journal of Surgery·Ayper InceMahmut Bülbül
Jun 20, 2003·Chemotherapy·Ken NemotoYoichiro Miyake
Apr 28, 2004·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Kitty J JagerUNKNOWN Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD) Study Group
Jul 6, 2004·The Journal of Pharmacy and Pharmacology·G W HanlonW A Al-Rustamani
Jun 30, 2006·Hemodialysis International·Gihad E NesrallahRobert M Lindsay
Apr 27, 2007·The British Journal of Dermatology·L EckhartE Tschachler
Jul 11, 2008·Expert Opinion on Biological Therapy·Richard J MarcusVikram Gahlot
Jun 12, 2009·Kidney International·Rhianna MilesDavid W Johnson
Jul 16, 2010·Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis·Philip Kam-Tao LiUNKNOWN International Society for Peritoneal Dialysis
Jul 2, 2011·Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis·Joanna R GhaliStephen P McDonald
Aug 13, 2011·The New England Journal of Medicine·Najib M RahmanRobert J O Davies
Nov 1, 2011·Journal of Renal Care·Edward Appiah Boateng, Linda East
May 26, 2012·Journal of the American Society of Nephrology : JASN·Neil BoudvilleDavid W Johnson
Aug 3, 2012·Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis·Maria PihlGunnel Svensäter
Mar 20, 2013·Indian Journal of Medical Microbiology·V A Kumar
Apr 17, 2013·Nephrology·Mark A BrownIlse Berquier
May 22, 2013·Nature Reviews. Nephrology·Simon J Davies
Oct 10, 2013·Seminars in Dialysis·Arshia GhaffariAllen Nissenson

❮ Previous
Next ❯

Citations

Sep 10, 2019·International Journal of Medical Microbiology : IJMM·Prince SharmaRavinder Singh
Oct 12, 2021·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Valentina BrunoElizabeth Harvey

❮ Previous
Next ❯

Methods Mentioned

BETA
lavage

Software Mentioned

GraphPad
Prism

Related Concepts

Related Feeds

Biofilm & Infectious Disease

Biofilm formation is a key virulence factor for a wide range of microorganisms that cause chronic infections.Here is the latest research on biofilm and infectious diseases.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Biofilms

Biofilms are adherent bacterial communities embedded in a polymer matrix and can cause persistent human infections that are highly resistant to antibiotics. Discover the latest research on Biofilms here.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Related Papers

Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association
Roman FiedlerThomas Langer
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis
M M PannekeetR T Krediet
Clinical Journal of the American Society of Nephrology : CJASN
Anouk T N van DiepenSarbjit V Jassal
© 2022 Meta ULC. All rights reserved